Cargando…
Risk-Stratified Therapy for Pediatric Acute Myeloid Leukemia
SIMPLE SUMMARY: Owing to the 40-year worldwide efforts for improving diagnosis and therapy for acute myeloid leukemia (AML), the second most common type of leukemia in children, overall survival rates of children with AML have now reached 70% to 80% in developed countries. This review article compre...
Autores principales: | Tomizawa, Daisuke, Tsujimoto, Shin-Ichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452723/ https://www.ncbi.nlm.nih.gov/pubmed/37627199 http://dx.doi.org/10.3390/cancers15164171 |
Ejemplares similares
-
Genome-wide DNA methylation analysis in pediatric acute myeloid leukemia
por: Yamato, Genki, et al.
Publicado: (2022) -
Molecular-Targeted Therapy of Pediatric Acute Myeloid Leukemia
por: Obszański, Piotr, et al.
Publicado: (2022) -
High-Risk Acute Myeloid Leukemia: A Pediatric Prospective
por: Cacace, Fabiana, et al.
Publicado: (2022) -
New and Emerging Targeted Therapies for Pediatric Acute Myeloid Leukemia (AML)
por: Chen, Jing, et al.
Publicado: (2020) -
Acute myeloid leukemia stratifies as two clinically relevant sphingolipidomic subtypes
por: Paudel, B. Bishal, et al.
Publicado: (2023)